MediPharm Labs Corp. (LABS) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the MediPharm Labs conference call to discuss the company's 26 Q2 results. Our speaker on today's call is Greg Hunter, Interim CEO and Chief Financial Officer. As a reminder, all participants are in listen-only mode and the conference is being recorded. After management's presentation, we will take written questions through the Q&A feature on the webcast. The information during this call should be considered together with the more detailed information, disclosure, financial data, and statements available on the company's website and on its CDAR profile at cdarplus.ca. As set out on the webcast slide, I would like to note that remarks during this call may contain forward-looking information and forward-looking statements within the meanings of applicable securities laws. This includes, without limitation, statements about many pharma labs, and its current and future plans, expectations, intentions, results, operations, levels of activity, performance, goals or achievements and other future events, trends, profitability, business growth or developments. All statements other than statements of historical fact are forward-looking statements. The statements made are based on the company's current expectations, estimates and beliefs as of today's date. The company's remarks may also contain references to certain non-IFRS financial measures, including adjusted EBITDA. These measures do not have any standardized meaning according to International Financial Reporting Standards, or IFRS, and therefore may not be comparable to similar measures presented by other companies. Please review the company's most recent disclosure materials filed on CDAR+. for the risks associated with forward-looking information and the use of non-IFRS financia...